Tag: generic drug safety
How FDA Monitors Generic Drug Safety After Approval
Mar, 31 2026
Discover how the FDA monitors generic drug safety after approval, including key surveillance systems, limitations, and future technological improvements.
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
Dec, 15 2025
The FDA monitors generic drugs after approval using real-world data, adverse event reports, and AI tools to ensure ongoing safety. Despite bioequivalence testing, post-market surveillance catches rare side effects and manufacturing issues that clinical trials miss.